ArticleCell cycle (Georgetown, Tex.)2019

TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).

Brittany Bunch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.